Skip to main content
. 2020 Sep 25;7(6):3841–3850. doi: 10.1002/ehf2.12974

FIGURE 5.

FIGURE 5

Data of the comparative analysis for the safety outcomes of hyperkalaemia and angioedema. Hyperkalaemia was defined as serum potassium >5.5 mmol/L. Sac/Val, sacubitril‐valsartan.